Menu

September 20, 2018, 12:00 pm – 1:30 pm CT / 1:00 pm – 2:30 pm ET

 Drug Diversion:
The 2018 Crisis Update & Our Future 

Session Overview

Kimberly New has been a terrific speaker for us on drug diversion who is back by popular demand. She is a specialist in controlled substance security and DEA regulatory compliance and consults with healthcare facilities across the country. She is an attorney and an RN who will provide a 2018 update on practical and powerful insights to the exploding drug diversion problem.  She is widely published and advises a number of leading medical centers.

The webinar for this month is an update to the drug diversion crisis following the excellent and informative programs she led January 18th of 2018 and September 21st of 2017.

A reactor panel of patient advocates and subject specific experts will react to the presentation.

We offer these online webinars at no cost to our participants.

……………………………………………………………………………………………………..

Click here to download the National Survey Results.  

Speaker Slide Set:

Click here to download the combined speakers’ slide set in PDF format – one (1) slide per page.   

To view the file, click the desired link (please note: the files may take several minutes to download). To save to your hard drive, right click on the link and choose “Save Target As.” (In some browsers it might say “Save Link As.”)

……………………………………………………………………………………………………..

Registration Information and CE Credit Information

 Register:  This webinar has previously taken place.  Refer to the webinar video above.

  When:  September 20, 2018   Time: 12:00 pm – 1:30 pm CT / 1:00 pm – 2:30 pm ET
We are accepting questions now that relate to the session topics. Please e-mail any questions related to the specific session to webinars@safetyleaders.org with the session title in the e-mail message header.

  • Questions about the Webinar series?
    E-mail webinars@safetyleaders.org or call 512-473-2370 between 9:00 a.m. and 4:30 p.m. CT.
  • Need technical assistance with registration? Call 512-457-7605 between 9:00 a.m. and 4:30 p.m. CT.

Learning Objectives:

  • Awareness:  Participants will understand and be able to discuss important Drug Diversion issues related to patient and caregiver safety in light of the exploding opioid crisis in 2018.
  • Accountability:  Participants will understand who may be accountable for responding to, and prioritizing, the opportunities for a drug diversion program related to patient and caregiver safety.
  • Ability:  Participants will learn about competencies important to developing and running a drug diversion program related to patient and caregiver safety.
  • Action:  Participants will learn what actions they may need to take in order to reduce the patient safety and caregiver safety risk related to behaviors of staff and patients related to drug diversion at a healthcare organization.

CE Participation Documentation

Texas Medical Institute of Technology, approved by the California Board of Registered Nursing, Provider Number 15996, will be issuing 1.5 contact hours for this webinar. TMIT is only providing nursing credit at this time.

To request a Participation Document, please click here.

……………………………………………………………………………………………………..

Session Speakers and Panelists

Kimberly S. New, JD, BSN, RN
Kimberly S. New, JD, BSN, RN Drug Diversion - A Drill Down Approach
Bio
William Adcox, MBA
William Adcox, MBADiscussion and Reaction to Presentation
Bio
Vicki King, MSCJ
Vicki King, MSCJDiscussion and Reaction to Presentation
Bio
C. R. Denham, II, MD
C. R. Denham, II, MDIn the News and Recent Polling
Bio
Arlene Salamendra
Arlene SalamendraDiscussion and Reaction to Presentation AND the Voice of Patient and Family
Bio

Related Resources

  1. Forbes; March 8, 2018; Clinical Drug Diversion: A Silent, Preventable Scourge In Our Nation’s Health Systems; https://www.forbes.com/sites/forbestechcouncil/2018/03/08/clinical-drug-diversion-a-silent-preventable-scourge-in-our-nations-health-systems/#b7e9db134ff2   
  2. U.S. News; March 2, 2018; What to Do About Drug Diversion in Hospitals; https://health.usnews.com/health-care/for-better/articles/2018-03-02/what-to-do-about-drug-diversion-in-hospitals  
  3. National Quality Forum. Safe Practice 1: Culture of Safety Leadership Structures and Systems. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at
    http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  4. National Quality Forum. Safe Practice 2: Culture Measurement, Feedback, and Intervention. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  5. National Quality Forum. Safe Practice 3: Teamwork Training and Skill Building. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  6. National Quality Forum. Safe Practice 4: Risks and Hazards. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  7. National Quality Forum. Safe Practice 18: Pharmacist Leadership Structures and Systems. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  8. National Quality Forum. Chapter 9: Opportunities for Patient and Family Involvement. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   

In the News

  1. JAMA; Aug 30, 2018; Financial Conflicts of Interest Among Oncologist Authors of Reports of Clinical Drug Trials; https://jamanetwork.com/journals/jamaoncology/article-abstract/2698041  
  2. The New York Times; Sep. 09, 2018; MSK Cancer Center Orders Staff to ‘Do a Better Job’ of Disclosing Industry Ties; https://www.nytimes.com/2018/09/09/health/cancer-memorial-sloan-kettering-disclosure.html  
  3. Modern Healthcare; Sept. 15, 2018; #MeToo era highlights importance of emergency CEO succession plans; http://www.modernhealthcare.com/article/20180915/NEWS/180919919?utm_source=modernhealthcare&utm_campaign=am&utm_medium=email&utm_content=20180915-NEWS-180919919  
  4. The Atlantic; Oct. 2018; A Shocking Number of Killers Murder Their Co-workers; https://www.theatlantic.com/magazine/archive/2018/10/the-killer-in-the-cubicle/568303  
  5. People; Dec. 14, 2018; Teen’s Family Reveals the Intense Bullying Before Her Suicide in Front of Them: ‘It Was Stalking’; https://people.com/crime/cyberbullied-teen-brandy-vela-family  
  6. US Depart. Of Justice; Aug. 22, 2018; Attorney General Sessions Makes Multiple Major Announcements as the Justice Department Continues to Combat the Opioid Crisis; https://www.justice.gov/opa/speech/attorney-general-sessions-makes-multiple-major-announcements-justice-department-continues